Company / Debt per Share
Vera Therapeutics, Inc. Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.17
FY2025
5-year range
$0.37 / $1.17
FY2021-FY2025
Trend
+27.2%
vs FY2024
Sector context
#55 of 82
Health Care
What the data says
At $1.17, Vera Therapeutics, Inc.'s debt per share ranks #28 of 82 in the Health Care sector.
Based on SEC 10-K filings.
1.17 in FY2025 with a 3-year CAGR of +7.7%.
Remained stable around $1.17 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#28 of 82 in Health CareTop 33% of 82This company $1.17 Sector average $151.59
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, debt per share increased 27.2% year-over-year.
- Ranks #55 out of 82 companies in the Health Care sector.
- Peak debt per share was recorded in FY2023.
- Lowest debt per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.17 | +27.2% |
| FY2024 | $0.92 | -21.6% |
| FY2023 | $1.17 | +25.1% |
| FY2022 | $0.93 | +154.8% |
| FY2021 | $0.37 | - |
| FY2020 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026